3124 J ournal of Medicinal Chemistry, 2003, Vol. 46, No. 14
Lee et al.
H, J ) 8.3 Hz), 6.8-7.05 (m, 3 H), 6.28 (m, 1 H, NH), 6.08 (bs,
1 H, NH), 4.44 (bs, 2 H, CSNHCH2Ar), 4.17 (m, 1 H, CH2OCO),
3.7-3.85 (m, 2 H, CH2OCO and CHCH2NHCS), 3.27 (m, 1 H,
CHCH2NHCS), 2.5-2.7 (m, 2 H, CH2Ar), 2.1-2.4 (m, 10 H, 2
× CH3, COCH3 and CH), 1.23 (d, 9 H, J ) 3.9 Hz, C(CH3)3)
MS (FAB) m/z 484 (MH+); Anal. (C27H37N3O3S) C, H, N, S.
N-[2-(3,4-Dim et h ylb en zyl)-3-(p iva loyloxy)p r op yl]-N′-
[4-(isobu tylca r bon yla m in o)ben zyl]th iou r ea (47): white
H, NHSO2), 6.39 (m, 1 H, NH), 6.12 (bs, 1 H, NH), 4.53 (bs, 2
H, CSNHCH2Ar), 4.40 (m, 1 H, CH2OCO), 4.08 (m, 1 H,
CH2OCO), 3.80 (m, 1 H, CHCH2NHCS), 3.38 (m, 1 H, CHCH2-
NHCS), 2.97 (s, 3 H, SO2CH3), 2.6-2.75 (m, 2 H, CH2Ar), 2.48
(m, 1 H, CH), 1.29 (s, 9 H, C(CH3)3); MS (FAB) m/z 568 (MH+);
Anal. (C30H37N3O4S2) C, H, N, S.
N-[2-(3,4-Dim et h ylb en zyl)-3-(p iva loyloxy)p r op yl]-N′-
[3-m eth oxy-4-(m eth ylsu lfon ylam in o)ben zyl]th iou r ea (57):
white solid, mp ) 49 °C; 1H NMR (CDCl3) δ 7.48 (d, 1 H, J )
8.0 Hz), 6.85-7.1 (m, 5 H), 6.77 (s, 1 H, NHSO2), 6.31 (m, 1
H, NH), 5.98 (bs, 1 H, NH), 4.49 (bs, 2 H, CSNHCH2Ar), 4.18
(m, 1 H, CH2OCO), 3.7-3.85 (m, 2 H, CH2OCO and CHCH2-
NHCS), 3.88 (s, 3 H, OCH3), 3.22 (m, 1 H, CHCH2NHCS), 2.93
(s, 3 H, SO2CH3), 2.5-2.7 (m, 2 H, CH2Ar), 2.2-2.4 (m, 7 H, 2
× CH3 and CH), 1.23 (d, 9 H, J ) 4.1 Hz, C(CH3)3); MS (FAB)
m/z 550 (MH+); Anal. (C27H39N3O5S2) C, H, N, S.
1
solid, mp ) 65 °C; H NMR (CDCl3) δ 7.50 (d, 2 H, J ) 8.3
Hz), 7.24 (d, 2 H, J ) 8.3 Hz), 6.8-7.05 (m, 3 H), 6.25 (m, 1 H,
NH), 6.00 (bs, 1 H, NH), 4.42 (bs, 2 H, CSNHCH2Ar), 4.12 (m,
1 H, CH2OCO), 3.7-3.85 (m, 2 H, CH2OCO and CHCH2-
NHCS), 3.25 (m, 1 H, CHCH2NHCS), 2.5-2.7 (m, 3 H, CH2Ar
and CHMe2), 2.15-2.3 (m, 7 H, 2 × CH3 and CH), 1.25 (m, 15
H, C(CH3)3 and CH(CH3)2); MS (FAB) m/z 512 (MH+); Anal.
(C29H41N3O3S) C, H, N, S.
N-[2-(3,4-Dim et h ylb en zyl)-3-(p iva loyloxy)p r op yl]-N′-
[3-(m eth ylsu lfon ylam in o)ben zyl]th iou r ea (48): white solid,
mp ) 51-54 °C; H NMR (CDCl3) δ 6.85-7.35 (m, 7 H, Ar),
N-[2-(4-ter t-Bu t ylb en zyl)-3-p iva loyloxyp r op yl]-N′-[3-
m eth oxy-4-(m eth ylsu lfon yla m in o)ben zyl]th iou r ea (58):
white solid, mp ) 62 °C; 1H NMR (CDCl3) δ 7.43 (d, 1 H, J )
8.1 Hz), 7.30 (d, 2 H, J ) 8.3 Hz), 7.10 (d, 2 H, J ) 8.3 Hz),
6.93 (s, 1 H), 6.88 (d, 1 H, J ) 8.1 Hz), 6.81 (s, 1 H, NHSO2),
6.39 (t, 1 H, NH), 6.24 (bs, 1 H, NH), 4.52 (bs, 2 H,
CSNHCH2Ar), 4.15 (dd, 1 H, J ) 3.6, 11.2 Hz, CH2OCO), 3.7-
3.9 (m, 2 H, CH2OCO and CHCH2NHCS), 3.87 (s, 3 H, OCH3),
3.25 (m, 1 H, CHCH2NHCS), 2.92 (s, 3 H, SO2CH3), 2.5-2.7
(m, 2 H, CH2Ar), 2.30 (m, 1 H, CH), 1.29 (s, 9 H, C(CH3)3),
1.23 (s, 9 H, C(CH3)3); MS (FAB) m/z 578 (MH+); Anal.
(C29H43N3O5S2) C, H, N, S.
1
6.3-6.4 (bs, 3 H, NH), 4.57 (bs, 2 H, NHCH2Ar), 4.12 (m, 1 H,
OdCOCH2), 3.85 (m, 1 H, OdCOCH2), 3.71 (m, 1 H, CHCH2-
NHCdS), 3.29 (m, 1 H, CHCH2NHCdS), 2.99 (s, 3 H, SO2CH3),
2.55-2.64 (m, 2 H, CH2Ph), 2.2-2.3 (m, 7 H, 2 × CH3 and
CHCH2NHCdS), 1.24 (s, 9 H, (CH3)3CO2); IR (KBr) 3364 (NH),
3250 (NH), 1715 (CdO), 1326 (SO2N), 1286 (N-CS-N), 1150
(SO2N) cm-1; MS (FAB) m/z 520 (MH+); Anal. (C26H37N3O4S2)
C, H, N, S.
N-[2-(3,4-Dim et h ylb en zyl)-3-(p iva loyloxy)p r op yl]-N′-
{[4-(m eth ylsu lfon yla m in o)m eth yl]ben zyl}th iou r ea (49):
N-[3-Ben zoyloxy-2-(3,4-d im eth ylben zyl)p r op yl]-N′-[3-
m eth oxy-4-(m eth ylsu lfon yla m in o)ben zyl]th iou r ea (59):
white solid, mp ) 62 °C; 1H NMR (CDCl3) δ 8.02 (m, 2 H),
7.60 (m, 1 H), 7.4-7.5 (m, 3 H), 6.8-7.1 (m, 5 H), 6.77 (s, 1 H,
NHSO2), 6.38 (m, 1 H, NH), 6.10 (bs, 1 H, NH), 4.50 (bs, 2 H,
CSNHCH2Ar), 4.42 (m, 1 H, CH2OCO), 4.05 (m, 1 H, CH2OCO),
3.82 (m, 1 H, CHCH2NHCS), 3.85 (s, 3 H, OCH3), 3.37 (m, 1
H, CHCH2NHCS), 2.92 (s, 3 H, SO2CH3), 2.6-2.8 (m, 2 H,
CH2Ar), 2.45 (m, 1 H, CH), 2.2-2.3 (m, 6 H, 2 × CH3); MS
(FAB) m/z 570 (MH+); Anal. (C29H35N3O5S2) C, H, N, S.
1
white solid, mp ) 39 °C; H NMR (CDCl3) δ 7.25-7.35 (m, 4
H), 6.85-7.05 (m, 3 H, aromatic), 6.31 (bs, 1 H, NH), 6.22 (bs,
1 H, NH), 5.04 (bs, 1 H, NH), 4.49 (bs, 2 H, NHCH2Ar), 4.35
(d, 2 H, J ) 5.7 Hz, CH2NHSO2CH3), 3.92 (m, 1 H, OdCOCH2),
3.72 (m, 1 H, OdCOCH2), 3.48 (m, 1 H, CHCH2NHCdS), 3.22
(m, 1 H, CHCH2NHCdS), 2.89 (s, 3 H, SO2CH3), 2.5-2.64 (m,
2 H, CH2Ph), 2.2-2.3 (m, 7 H, 2 × CH3 and CHCH2NHCdS),
1.22 (s, 9 H, (CH3)3CO2); IR (KBr) 3355 (NH), 1716 (CdO),
1318 (SO2N), 1286 (N-CS-N), 1150 (SO2N) cm-1; MS (EI) m/z
532 (M+ - 1); Anal. (C27H39N3O4S2) C, H, N, S.
N-[3-Ben zoyloxy-2-(4-ter t-b u t ylb en zyl)p r op yl]-N′-[3-
m eth oxy-4-(m eth ylsu lfon yla m in o)ben zyl]th iou r ea (60):
white solid, mp ) 57 °C; 1H NMR (CDCl3) δ 8.02 (dd, 2 H, J )
7.1, 1.5 Hz), 7.60 (m, 1 H), 7.47 (m, 3 H), 7.32 (d, 2 H, J ) 8.3
Hz), 7.15 (d, 2 H, J ) 8.3 Hz), 6.85-6.95 (m, 2 H), 6.77 (s, 1
H, NHSO2), 6.38 (t, 1 H, NH), 6.08 (bs, 1 H, NH), 4.51 (bs, 2
H, CSNHCH2Ar), 4.42 (dd, 1 H, J ) 3.9, 11.7 Hz, CH2OCO),
4.05 (m, 1 H, CH2OCO), 3.82 (m, 1 H, CHCH2NHCS), 3.86 (s,
3 H, OCH3), 3.37 (m, 1 H, CHCH2NHCS), 2.92 (s, 3 H,
SO2CH3), 2.5-2.7 (m, 2 H, CH2Ar), 2.45 (m, 1 H, CH), 1.29 (s,
9 H, C(CH3)3); MS (FAB) m/z 598 (MH+); Anal. (C31H39N3O5S2)
C, H, N, S.
Gen er a l P r oced u r e for t h e Syn t h esis of Th iou r ea s
(54-61). A suspension of azide (50-53) (0.5 mmol) and Lindlar
catalyst (50 mg) in ethanol (5 mL) was hydrogenated under a
balloon of hydrogen for 2 h. The mixture was filtered, and the
filtrate was concentrated in vacuo. The residue was dissolved
in dichloromethane (5 mL) and added with isocyanate (36-
38) (0.5 mmol). After being stirred for 24 h at room temper-
ature, the mixture was concentrated in vacuo, and the residue
was purified by flash column chromatography over silica gel
with EtOAc/hexanes (1:1) as eluant to afford thiourea.
N-[2-(4-ter t-Bu t ylb en zyl)-3-p iva loyloxyp r op yl]-N′-[4-
(m eth ylsu lfon yla m in o)ben zyl]th iou r ea (54): white solid,
mp ) 61 °C; 1H NMR (CDCl3) δ 7.30 (d, 4 H, J ) 8.5 Hz), 7.18
(d, 2 H, J ) 8.6 Hz), 7.11 (d, 2 H, J ) 8.6 Hz), 6.51 (s, 1 H,
NHSO2), 6.33 (m, 1 H, NH), 6.02 (bs, 1 H, NH), 4.53 (bs, 2 H,
CSNHCH2Ar), 4.16 (dd, 1 H, CH2OCO), 3.7-3.85 (m, 2 H,
CH2OCO and CHCH2NHCS), 3.22 (m, 1 H, CHCH2NHCS),
2.99 (s, 3 H, SO2CH3), 2.6-2.7 (m, 2 H, CH2Ar), 2.32 (m, 1 H,
CH), 1.29 (s, 9 H, C(CH3)3), 1.23 (s, 9 H, C(CH3)3); MS (FAB)
m/z 548 (MH+); Anal. (C28H41N3O4S2) C, H, N, S.
N-[2-(3,4-Dim et h ylb en zyl)-3-(p iva loyloxy)p r op yl]-N′-
[3-flu or o-4-(m eth ylsu lfon yla m in o)ben zyl]th iou r ea (61):
white solid, mp ) 56 °C; 1H NMR (CDCl3) δ 7.45 (d, 2 H, J )
8.3 Hz), 6.85-7.15 (m, 5 H), 6.53 (bs, 2 H, NHCS), 4.58 (bs, 2
H, CSNHCH2Ar), 4.14 (dd, 1 H, J ) 3.9, 11.7 Hz, CH2OCO),
3.6-3.9 (m, 2 H, CH2OCO and CHCH2NHCS), 3.25 (m, 1 H,
CHCH2NHCS), 2.99 (s, 3 H, SO2CH3), 2.5-2.7 (m, 2 H, CH2Ar),
2.2-2.4 (m, 7 H, 2 × CH3 and CH), 1.23 (d, 9 H, J ) 3.9 Hz,
C(CH3)3); MS (FAB) m/z 538 (MH+); Anal. (C26H36FN3O4S2) C,
H, N, S.
N-[3-Ben zoyloxy-2-(3,4-d im eth ylben zyl)p r op yl]-N′-[4-
(m eth ylsu lfon yla m in o)ben zyl]th iou r ea (55): white solid,
1
mp ) 46 °C; H NMR (CDCl3) δ 8.0 (m, 2 H), 7.59 (m, 1 H),
VR1 Bin d in g Assa ys. Cell Cu ltu r e. The pUHG102 VR1
plasmid was transfected into CHO cells containing the pTet
Off regulatory plasmid (Clontech). In these cells, expression
of the VR1 is repressed in the presence of tetracycline but is
induced upon removal of the antibiotic. Stable clones were
isolated in culture medium containing puromycin (10 µg/mL)
and maintained in HAM F12 medium supplemented with
tetracycline (1 µg/mL), 5 µg/mL geniticin, 25 mM HEPES, 10%
FBS. Cells utilized for assays were grown in culture medium
without antibiotic for 48 h before use. Cells were seeded in
T75 cell culture flasks in media without antibiotics and grown
to approximately 90% confluence. The flasks were then washed
with PBS and harvested in 0.25% trypsin, 1 mM EDTA. The
7.45 (m, 2 H), 7.29 (bs, 1 H, NHSO2), 7.24 (d, 2 H, J ) 8.3 Hz),
7.15 (d, 2 H, J ) 8.3 Hz), 6.85-7.05 (m, 3 H), 6.40 (m, 1 H,
NH), 6.09 (bs, 1 H, NH), 4.52 (bs, 2 H, CSNHCH2Ar), 4.37 (m,
1 H, CH2OCO), 4.10 (m, 1 H, CH2OCO), 3.80 (m, 1 H, CHCH2-
NHCS), 3.41 (m, 1 H, CHCH2NHCS), 2.94 (s, 3 H, SO2CH3),
2.6-2.8 (m, 2 H, CH2Ar), 2.44 (m, 1 H, CH), 2.2-2.4 (m, 6 H,
2 × CH3); MS (FAB) m/z 540 (MH+); Anal. (C28H33N3O4S2) C,
H, N, S.
N-[3-Ben zoyloxy-2-(4-ter t-b u t ylb en zyl)p r op yl]-N′-[4-
(m eth ylsu lfon yla m in o)ben zyl]th iou r ea (56): white solid,
mp ) 68 °C; 1H NMR (CDCl3) δ 8.02 (d, 2 H), 7.60 (t, 1 H)
7.47 (t, 2 H), 7.25-7.35 (m, 4 H), 7.1-7.2 (m, 4 H), 6.54 (s, 1